December 18, 2018

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
18
Dec
Brewery Defeats Trademark Opposition by Conservative Public Figure Phyllis Schlafly Mintz
18
Dec
Belch! Ocean Spray Price Premium Damages Model Passes Comcast Scrutiny Carlton Fields
18
Dec
Fishy Business: Seafood Fraud in New York State Keller and Heckman LLP
18
Dec
Oregon Considers Tax on Plastic Bags Keller and Heckman LLP
17
Dec
New York Tightens Its Grip on CBD Even as the Feds Ease Industrial Hemp Restrictions Wilson Elser Moskowitz Edelman & Dicker LLP
17
Dec
ISO Publishes Specification for Developing Representative Test Materials Consisting of Nano-Objects in Dry Powder Form Bergeson & Campbell, P.C.
17
Dec
Will California’s Cannabis Regulation Limit Commercial Activity Between Licensed and Unlicensed Entities? Wilson Elser Moskowitz Edelman & Dicker LLP
17
Dec
FSIS Announces Move from Pulsed-Field Gel Electrophoresis to Whole Genome Sequencing for Analyzing Shiga Toxin-Producing E. coli (STEC) and Salmonella Isolates Keller and Heckman LLP
16
Dec
EPA Regulatory Environmental Law News Update November 2018 Bergeson & Campbell, P.C.
14
Dec
McDermottPlus Check-Up: December 14, 2018 McDermott Will & Emery
14
Dec
FDA Releases Medical Device De Novo Pathway Proposed Rule Dinsmore & Shohl LLP
14
Dec
FDA and CDC Identify One Source of E. Coli Contaminated Romaine Keller and Heckman LLP
13
Dec
Some BPCIA Clouds Begin to Clear: FDA Issues Final Plans for March 2020 “Deemed to Be a License” Provision Mintz
13
Dec
Contrary to Popular Reports, Farm Bill Will Not Affect FDA Status of CBD Keller and Heckman LLP
12
Dec
Top International News in Chemical Policy and Regulation: December 12, 2018: European Union Bergeson & Campbell, P.C.
12
Dec
FDA Issues Real-World Evidence Framework for Drugs and Biologics McDermott Will & Emery
12
Dec
Second Circuit Remands “Whole Grain” Cheez-It Lawsuit Keller and Heckman LLP
11
Dec
THE LATEST: FTC Submits Comment on FDA Guidance Aimed at Deterring Abuse of Citizen Petition Process McDermott Will & Emery
11
Dec
FDA to Overhaul Medical Device Approval Process Epstein Becker & Green, P.C.
11
Dec
Mixed Reactions to Final Rule on School Meal Flexibilities Keller and Heckman LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS